Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells

Oncogene

Volumn 24, Issue 14, 2005, Pages 2307-2316

  Gonzalez Guerrico, Anatilde M ^a,c   Jaffer, Zahara M ^a   Page, Robert E ^a   Braunewell, Karl Heinz ^b   Chernoff, Jonathan ^a   Klein Szanto, Andres J P ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adhesion; Integrins; Migration; Squamous cell carcinoma (SCC); Visinin like protein 1 (VILIP 1)

Indexed keywords

ALPHA5 INTEGRIN; ANTIBODY; CALCIUM; CD51 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FIBRONECTIN; FIBRONECTIN RECEPTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VISININ; VISININ LIKE PROTEIN 1; CALCIUM SENSING RECEPTOR; INTEGRIN; NERVE PROTEIN; NEUROCALCIN; PRIMER DNA; VSNL1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL SUBPOPULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; ANIMAL; CELL MOTION; DRUG ANTAGONISM; IMMUNOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA PRIMERS; INTEGRINS; MICE; NERVE TISSUE PROTEINS; NEUROCALCIN; RECEPTORS, CALCIUM-SENSING;

EID: 16444365455     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208476     Document Type: Article

References (39)

1. Adams JC and Watt FM. (1991). J. Cell Biol., 115, 829-841.
2. Bagutti C, Speight PM and Watt FM. (1998). J. Pathol., 186, 8-16.
3. Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B and Hensler M. (2002). Clin. Exp. Metast., 19, 427-436.
4. Gong J, Wang D, Sun L, Zborowska E, Willson JK and Brattain MG. (1997). Cell Growth Differ., 8, 83-90.
5. Haapasalmi K, Zhang K, Tonnesen M, Olerud J, Sheppard D, SaIo T, Kramer R, Clark RA, Uitto VJ and Larjava H. (1996). J. Invest. Dermatol., 106, 42-48.
6. Hood JD and Cheresh DA. (2002). Nat. Rev. Cancer, 2, 91-100.
7. Huang S, Stupack D, Liu A, Cheresh D and Nemerow GR. (2000). Oncogene, 19, 1915-1923.
8. Hubbard FC, Goodrow TL, Liu SC, Brilliant MH, Basset P, Mains RE and Klein-Szanto AJ. (1997). Cancer Res., 57, 5226-5231.
9. Jin H and Varner J. (2004). Br. J. Cancer, 90, 561-565.
10. Jones J, Watt FM and Speight PM. (1997). J. Oral Pathol. Med., 26, 63-68.
11. Kassis J, Lauffenburger DA, Turner T and Wells A. (2001). Semin. Cancer Biol., 11, 105-117.
12. Kerr JS, Slee AM and Mousa SA. (2002). Expert Opin. Investig. Drugs, 11, 1765-1774.
13. Kikuchi M, Ma TY, Tarnawski AS, Shimada H and Sarfeh IJ. (1997). J. Gastrointest. Surg., 1, 132-137.
14. Kim S, Harris M and Varner JA. (2000). J. Biol. Chem., 275, 33920-33928.
15. Koivisto L, Grenman R, Heino J and Larjava H. (2000). Exp. Cell Res., 255, 10-17.
16. Koivisto L, Larjava K, Hakkinen L, Uitto VJ, Heino J and Larjava H. (1999). Cell Adhes. Commun., 7, 245-257.
17. Koukoulis GK, Warren WH, Virtanen I and Gould VE. (1997). Hum. Pathol., 28, 1018-1025.
18. Larjava H, Salo T, Haapasalmi K, Kramer RH and Heino J. (1993). J. Clin. Invest., 92, 1425-1435.
19. Li X, Regezi J, Ross FP, Blystone S, Ilic D, Leong SP and Ramos DM. (2001). J. Cell Sci., 114, 2665-2672.
20. Ma TY, Kikuchi M, Sarfeh IJ, Shimada H, Hoa NT and Tarnawski AS. (1999). J. Lab. Clin. Med., 134, 363-371.
21. Mahloogi H, Gonzalez-Guerrico AM, Lopez De Cicco R, Bassi DE, Goodrow T, Braunewell KH and Klein-Szanto AJ. (2003). Cancer Res., 63, 4997-5004.
22. Mercuric AM and Rabinovitz I. (2001). Semin. Cancer Biol., 11, 129-141.
23. Nagaoka K, Nojima H, Watanabe F, Chang KT, Christenson RK, Sakai S and Imakawa K. (2003). J. Biol. Chem., 278, 29048-29056.
24. O'Connor KL, Nguyen BK and Mercuric AM. (2000). J. Cell Biol., 148, 253-258.
25. O'Connor KL, Shaw LM and Mercurio AM. (1998). J. Cell Biol., 143, 1749-1760.
26. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ and Conklin DS. (2002). Genes Dev., 16, 948-958.
27. Paddison PJ, Caudy AA, Sachidanandam R and Hannon GJ. (2004). Methods Mol. Biol., 265, 85-100.
28. Peltonen J, Larjava H, Jaakkola S, Gralnick H, Akiyama SK, Yamada SS, Yamada KM and Uitto J. (1989). J. Clin. Invest., 84, 1916-1923.
29. Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF and Ellis LM. (2003). Cancer Res., 63, 2079-2087.
30. Rolli M, Fransvea E, Pilch J, Saven A and Felding-Habermann B. (2003). Proc. Natl. Acad. Sci. USA, 100, 9482-9487.
31. Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, Trono D, Conti CJ and Klein-Szanto AJ. (1991). Cancer Res., 51, 6615-6621.
32. Santibanez JF, Olivares D, Guerrero J and Martinez J. (2003). Int. J. Cancer, 107, 715-720.
33. Shiraha H, Glading A, Chou J, Jia Z and Wells A. (2002). Mol. Cell. Biol., 22, 2716-2727.
34. Takahashi K, Nakamura T, Koyanagi M, Kato K, Hashimoto Y, Yagita H and Okumura K. (1990). J. Immunol., 145, 4371-4379.
35. Thomas GJ, Lewis MP, Hart IR, Marshall JF and Speight PM. (2001a). Int. J. Cancer, 92, 641-650.
36. Thomas GJ, Lewis MP, Whawell SA, Russell A, Sheppard D, Hart IR, Speight PM and Marshall JF. (2001b). J. Invest. Dermatol., 117, 67-73.
37. Woodhouse EC, Chuaqui RF and Liotta LA. (1997). Cancer, 80, 1529-1537.
38. Yasuda M, Hasunuma Y, Adachi H, Sekine C, Sakanishi T, Hashimoto H, Ra C, Yagita H and Okumura K. (1995). Int. Immunol., 7, 251-258.
39. Zhang Z, Morla AO, Vuori K, Bauer JS, Juliano RL and Ruoslahti E. (1993). J. Cell Biol., 122, 235-242.